New UK prime minister Boris Johnson has pledged a £1.8 billion cash injection for the NHS as he ramps up plans for the country to leave the EU – with or without a deal – by October 31st.
The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded medicines spend; the 2019 Voluntary Scheme for Branded Medicines Pricing
